French Communications Stock News

Amundi (ENXTPA:AMUN) has just wrapped up a €500 million share buyback, retiring 5,900,000 shares, or 2.88% of its capital, with the plan officially closed on 18 September 2026. Recent trading has cooled slightly, with Amundi’s share price down 3.3% over the past month after a 9.8% gain across 90 days. However, the year-to-date share price return of 28.7% and 1-year total shareholder return of 46.4% point to firm upward momentum. Scan how Amundi’s buyback compares with other financial players...

Air France-KLM (ENXTPA:AF) has become a talking point after Air France decided to shift all New York JFK flights to the new Terminal One, along with a large flagship lounge aimed at premium travelers. For investors tracking Air France-KLM, the latest terminal and lounge upgrade comes as the share price closed at €11.44. The stock has eased over the past week and quarter, and the 1-year total shareholder return has also moved lower. This suggests that momentum has been fading, despite ongoing...

How Accor Stock Has Been Trading Recently Accor (ENXTPA:AC) has been trading around €45.58, with the hotel operator showing a mixed return profile. The shares are flat over the past month and down over the past 3 months. Short-term momentum for Accor looks softer, with the share price drifting lower over the past week and quarter. However, the 1-year total shareholder return of 13.65% and 5-year total shareholder return of 68.50% indicate that longer term holders have still been...

Exosens lifted its full-year 2026 guidance in September 2026, now targeting revenue of €558 million to €570 million, compared with a prior range of €520 million to €540 million. The company cited faster capacity ramp-up and solid demand in defense imaging and nuclear instrumentation. The upgraded outlook highlights how Exosens is turning expanded manufacturing capacity into higher expected earnings. This suggests that operational execution and uptake of mission-critical imaging across...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

SEB (ENXTPA:SK) has reshuffled its leadership, with the board appointing Loïc Moutault as Chief Executive Officer effective October 1, 2026, replacing Stanislas de Gramont at the end of his tenure. SEB’s latest leadership change comes as the share price trades at €56.4, with a 90 day share price return of 8.67% and a year to date gain of 14.36%, suggesting improving momentum. This is occurring even though the 1 year total shareholder return is down 3.56% and the 5 year total shareholder...

Boiron shares have been grinding lower for months, yet the latest half year report adds a fresh concern. The stock closed at €21.10 on 18 September, well below analyst fair value estimates, and the new headline is not revenue pressure. Earnings power is the issue. Basic earnings per share for the first half of 2026 came in at €0.28, set against a trailing twelve month net profit margin of 5.3% and a dividend yield of 6.4%, which is not well backed by free cash flow. Concerned that Boiron’s...

TotalEnergies (ENXTPA:TTE) has drawn fresh attention after agreeing a US$1.8b infrastructure partnership with Global Infrastructure Partners related to African oil and gas assets, with returns structured through throughput-based tariffs over a period of up to 15 years. Set against this new partnership, TotalEnergies’ share price has risen 11.61% over the past 90 days and 41.39% year to date, while the 1 year total shareholder return of 62.46% and 5 year total shareholder return of 162.27%...

Virbac shareholders watched the stock drift over recent weeks, with the price down roughly 9% over three months, then saw a fresh verdict land as the market absorbed half year numbers. The business just printed €768m in H1 2026 revenue and an adjusted earnings before interest and tax margin of 18.8%, which is high for an animal health specialist that is still investing heavily in growth platforms. The headline is simple: profitability held up while Virbac kept funding future products, and the...

Innate Pharma’s share price closed at €1.58 on Friday, leaving the stock lower over the past month while traders tried to make sense of a biotech story driven more by hope than current profit. The headline from these H1 2026 results is simple. Losses remain heavy, with net income excluding extra items at a loss of €19.6 million, yet the development portfolio and recent licensing deals mean sentiment is being pulled in two directions at once. Love the drug pipeline potential at Innate Pharma...

Sodexo (ENXTPA:SW) has been active in the market for its own shares, executing treasury purchases between 7 and 11 September 2026 under its existing buyback program to meet free share award commitments. Those buybacks come at a time when Sodexo’s momentum has been building, with a 1-day share price return of 2.93% contributing to a 35.06% year-to-date share price gain and a 42.40% total shareholder return over five years, despite a slightly negative 3-year total shareholder return. Scan how...

Schneider Electric (ENXTPA:SU) moved higher after the latest US Federal Reserve rate hike shifted sentiment across European equities. The stock reacted alongside peers as tighter policy pushed the dollar up and refocused attention on export and energy costs. For context, Schneider Electric’s share price has risen 21.11% year to date to €287.10, while the 1-year total shareholder return of 25.34% and 3-year total shareholder return of 94.37% point to momentum that has been building rather than...

Sanofi has opened the Charles Best Building in Toronto, a C$925 million flu vaccine facility that will produce Fluzone High-Dose for older adults and expand end to end manufacturing capacity in Canada, alongside a planned transfer of 20 mature medicines and three plants to Cheplapharm. The combination of a large-scale Canadian vaccine build-out and a shift of mature products and sites to Cheplapharm highlights Sanofi’s push to concentrate internal resources on higher value R&D and biologics,...

Exosens raises 2026 guidance and sharpens investor focus Exosens (ENXTPA:EXENS) lifted its full-year 2026 earnings guidance and now projects revenue between €558 million and €570 million, compared with an earlier range of €520 million to €540 million. The upgraded outlook has quickly fed into the market reaction, with Exosens’ 1-day share price return of 8.37% lifting the stock to €58.9 and partly reversing a 30-day share price decline of 5.38% and a 90-day share price fall of 2.00%. Even...

Xilam Animation ( EPA:ALXIL ), is not the largest company out there, but it saw significant share price movement during...

JCDecaux secured the exclusive 2m² outdoor advertising contract in Düsseldorf through a competitive tender, covering public areas and Rheinbahn bus and tram stops, which reinforces its operational role in this German city. The renewed exclusivity on compact street furniture directly supports JCDecaux's focus on recurring municipal contracts and transit advertising, areas that influence asset efficiency and contract-driven revenue visibility. We will now assess how JCDecaux's renewed...

Investor focus around Renault (ENXTPA:RNO) has sharpened after a special call on the Niagara project, while a fresh capital commitment to the Geely partnership in Brazil puts electrified models and emerging markets in sharper view. Recent activity around the Niagara briefing and the expanded Geely venture has arrived while Renault’s share price sits at €28.95, with a 1-day share price return of 2.41%, year to date share price performance down 20.38%, and a 5-year total shareholder return of...

Ipsos shares have drifted over the past few years, while the business pushes ahead with its Horizons plan under new leadership. The question now is whether the current price around €34.66 still lines up with what the company earns. The stock has declined 12.0% over the past three years, which puts the focus squarely on whether the earnings profile justifies staying invested. Kelly Beaver’s push to accelerate the Horizons strategic plan, with a heavier emphasis on global solutions, artificial...

AXA has delivered strong share-price gains in recent years, which puts a spotlight on whether the current valuation can still be backed up by its earnings power. With the stock trading around €45.06 at the last close, investors are increasingly asking how much of the insurer's earnings story is already reflected in that price. Over the past 5 years AXA has returned 158.9%, which makes the question of what earnings justify today's level far more important for anyone considering the stock...

The global hybrid aircraft market is drawing fresh attention as regulators tighten emissions rules and regional transport demand grows. Airbus (ENXTPA:AIR) is among the leading players in this segment, linking its sustainability push to potential long term revenue streams. Recent trading has been choppy for Airbus, with the share price at about €195.5 after declining roughly 6.8% over the past month. A 90 day share price return of 3.2% and a 1 year total shareholder return of 3.9% point to...

LNA Santé stock has drifted lower over the past week, yet the latest half year report tells a calmer story than the price chart suggests. The headline is simple: earnings per share and net profit held up, while revenue reached about €484 million for the first half of 2026. For a healthcare and elder care operator where thin profitability is the norm, even a modest net margin near 3% matters. The market is reacting to short term nerves, while the figures point to a business grinding forward,...

Covivio (ENXTPA:COV) has drawn investor attention after recent price moves, with the share price near €48.08 and performance over the past month and past 3 months showing clear declines. Short-term momentum for Covivio looks weak, with the 1-month share price return down 6.46% and the year-to-date share price return down 14.07%, even though the 3-year total shareholder return is up 37.56%. This hints at fading near-term enthusiasm despite a stronger long-run history. Scan beyond Covivio's...

Lagardere SA recently completed a €500 million, 6 year bond issue maturing in September 2032 with a fixed 5.25% annual coupon, using the funds to repay part of a June 2024 bank facility and a portion of the Vivendi loan while spreading out its debt maturities. This refinancing move provides Lagardere with more predictable financing costs and a longer runway to execute on travel retail, publishing, and portfolio reshaping priorities without near term debt pressures dominating management...

Valeo renewed its employee share subscription plan for around 81,000 staff across 21 countries and advanced plans to ramp high-voltage inverter production at its Étaples site for next generation electric vehicles. This twin focus on wider employee ownership and high-voltage electrification suggests management is concentrating capital and people on areas regarded as central to Valeo’s future operations. The next step is to examine how Valeo's broader investment narrative could be influenced...